» Articles » PMID: 9421490

Citrulline is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-specific Autoantibodies

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1998 Feb 14
PMID 9421490
Citations 470
Authors
Affiliations
Soon will be listed here.
Abstract

Only a few autoantibodies that are more or less specific for RA have been described so far. The rheumatoid factor most often tested for is not very specific for RA, while the more specific antiperinuclear factor for several reasons is not routinely used as a serological parameter. Here we show that autoantibodies reactive with synthetic peptides containing the unusual amino acid citrulline, a posttranslationally modified arginine residue, are specifically present in the sera of RA patients. Using several citrulline-containing peptide variants in ELISA, antibodies could be detected in 76% of RA sera with a specificity of 96%. Sera showed a remarkable variety in the reactivity pattern towards different citrulline-containing peptides. Affinity-purified antibodies were shown to be positive in the immunofluorescence-based antiperinuclear factor test, and in the so-called antikeratin antibody test, and were reactive towards filaggrin extracted from human epidermis. The specific nature of these antibodies and the presence of these antibodies early in disease, even before other disease manifestations occur, are indicative for a possible role of citrulline-containing epitopes in the pathogenesis of RA.

Citing Articles

Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides.

Haro I, Castellanos-Moreira R, Sanmarti R, Gomara M Diagnostics (Basel). 2024; 14(22).

PMID: 39594151 PMC: 11593125. DOI: 10.3390/diagnostics14222485.


A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation.

Bertran M, Walmsley R, Cummings T, Aramburu I, Benton D, Mora Molina R Nat Commun. 2024; 15(1):9746.

PMID: 39528459 PMC: 11555231. DOI: 10.1038/s41467-024-53554-1.


Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?.

Xu C, Jing W, Liu C, Yuan B, Zhang X, Liu L Front Immunol. 2024; 15:1343325.

PMID: 39450183 PMC: 11499118. DOI: 10.3389/fimmu.2024.1343325.


Limited Biomarker Potential for IgG Autoantibodies Reactive to Linear Epitopes in Systemic Lupus Erythematosus or Spondyloarthropathy.

Bashar S, Zheng Z, Mergaert A, Adyniec R, Gupta S, Amjadi M Antibodies (Basel). 2024; 13(4).

PMID: 39449329 PMC: 11503330. DOI: 10.3390/antib13040087.


The double-edged nature of nicotine: toxicities and therapeutic potentials.

Cao Y, Sun J, Wang X, Zhang X, Tian H, Huang L Front Pharmacol. 2024; 15:1427314.

PMID: 39206262 PMC: 11350241. DOI: 10.3389/fphar.2024.1427314.


References
1.
Kurki P, Aho K, Palosuo T, Heliovaara M . Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum. 1992; 35(8):914-7. DOI: 10.1002/art.1780350810. View

2.
Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M . Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis. 1992; 51(6):743-6. PMC: 1004738. DOI: 10.1136/ard.51.6.743. View

3.
Simon M, Girbal E, Sebbag M, Gomes-Daudrix V, Vincent C, Salama G . The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest. 1993; 92(3):1387-93. PMC: 288281. DOI: 10.1172/JCI116713. View

4.
Schellekens G, Lasonder E, Feijlbrief M, Koedijk D, Drijfhout J, Scheffer A . Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Eur J Immunol. 1994; 24(12):3188-93. DOI: 10.1002/eji.1830241241. View

5.
Dyson H, Wright P . Antigenic peptides. FASEB J. 1995; 9(1):37-42. DOI: 10.1096/fasebj.9.1.7821757. View